BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16623658)

  • 1. Clinical and imaging metrics for monitoring disease progression in patients with multiple sclerosis.
    Bagnato F; Ohayon JM; Ehrmantraut M; Chiu AW; Riva M; Ikonomidou VN
    Expert Rev Neurother; 2006 Apr; 6(4):599-612. PubMed ID: 16623658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.
    Zivadinov R; Minagar A
    J Neurol Sci; 2009 Jul; 282(1-2):1-4. PubMed ID: 19345379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MRS and fMRI in multiple sclerosis.
    Tartaglia MC; Arnold DL
    Adv Neurol; 2006; 98():185-202. PubMed ID: 16400835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord imaging in multiple sclerosis.
    Tench CR; Morgan PS; Jaspan T; Auer DP; Constantinescu CS
    J Neuroimaging; 2005; 15(4 Suppl):94S-102S. PubMed ID: 16385022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging advances in multiple sclerosis.
    Bakshi R
    J Neuroimaging; 2005; 15(4 Suppl):5S-9S. PubMed ID: 16385014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance techniques to quantify tissue damage, tissue repair, and functional cortical reorganization in multiple sclerosis.
    Filippi M; Agosta F
    Prog Brain Res; 2009; 175():465-82. PubMed ID: 19660674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
    Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
    J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging in multiple sclerosis.
    Zivadinov R; Cox JL
    Int Rev Neurobiol; 2007; 79():449-74. PubMed ID: 17531854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M; Grossman RI; Filippi M
    J Neuroimaging; 2005; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
    Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging biomarkers in multiple sclerosis.
    Filippi M; Agosta F
    J Magn Reson Imaging; 2010 Apr; 31(4):770-88. PubMed ID: 20373420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R; Leist TP
    J Neuroimaging; 2005; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI in multiple sclerosis.
    Simon JH
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):383-409, viii. PubMed ID: 15893678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A; León A
    Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.